The Anti-CD3-Induced Syndrome: A Consequence of Massive In Vivo Cell Activation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (61)
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
1987 • 2,769 citations
Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration
1988 • 1,711 citations
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
1987 • 1,644 citations
Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens
1979 • 1,480 citations
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
1989 • 1,462 citations
Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance
1986 • 1,305 citations
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
1989 • 1,269 citations
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
1985 • 896 citations
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.
1983 • 833 citations
The T Cell Receptor/CD3 Complex: A Dynamic Protein Ensemble
1988 • 786 citations
Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1
1986 • 781 citations
OKT3: A monoclonal anti-human T lymphocyte antibody with potent mitogenic properties
1980 • 718 citations
A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal Transplants
1985 • 697 citations
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
1988 • 599 citations
Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis
1990 • 581 citations
Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts
1981 • 511 citations
Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.
1988 • 510 citations
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
1985 • 466 citations
Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.
1984 • 390 citations
Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
1989 • 385 citations
Genetic Control of Leucocyte Responses to Endotoxin
1968 • 384 citations
Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.
1987 • 372 citations
RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS
1989 • 361 citations
Identification of the components of the murine T cell antigen receptor complex
1985 • 333 citations
Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis
1989 • 328 citations
IN VIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATION
1990 • 309 citations
Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?
1981 • 306 citations
Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
1986 • 302 citations
Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
1985 • 286 citations
Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation
1990 • 267 citations
Acute in vivo effects of human recombinant tumor necrosis factor.
1987 • 256 citations
Immunologic Properties of Bacterial Lipopolysaccharide (LPS): Correlation between the Mitogenic, Adjuvant, and Immunogenic Activities
1975 • 242 citations
Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype.
1986 • 241 citations
Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
1989 • 198 citations
The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins.
1983 • 194 citations
Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.
1988 • 172 citations
Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.
1986 • 171 citations
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
1986 • 161 citations
ANTI-CD3 F(abʼ)2 FRAGMENTS ARE IMMUNOSUPPRESSIVE IN VIVO WITHOUT EVOKING EITHER THE STRONG HUMORAL RESPONSE OR MORBIDITY ASSOCIATED WITH WHOLE mAb
1990 • 124 citations
The δ- and ε-chains of the human T3/T-cell receptor complex are distinct polypeptides
1984 • 113 citations
Characterization of the two heavy chains of the T3 complex on the surface of human T lymphocytes.
1984 • 107 citations
CORTICOSTEROID INHIBITION OF THE OKT3-INDUCED CYTOKINE-RELATED SYNDROME
1991 • 97 citations
Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.
1987 • 90 citations
Induction of T cell proliferation with anti‐CD3 switch‐variant monoclonal antibodies: effects of heavy chain isotype in monocyte‐dependent systems
1987 • 90 citations
Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis.
1989 • 89 citations
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.
1988 • 88 citations
Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia.
1990 • 87 citations
Transplantation: Approaches to graft rejection
1988 • 86 citations
Genetic control of endotoxic responses in mice.
1978 • 85 citations
Hypothermia and hypoglycemia induced by anti‐CD3 monoclonal antibody in mice: Role of tumor necrosis factor
1990 • 83 citations
Antigenic modulation - a major mechanism of antibody action
1984 • 76 citations
The T3/T cell receptor complex: antigenic distinction between the two 20-kd T3 (T3-delta and T3-epsilon) subunits.
1985 • 76 citations
EFFECTS OF IN VIVO ADMINISTRATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN T CELL SUBPOPULATIONS ON THE IMMUNE SYSTEM IN A RHESUS MONKEY MODEL
1983 • 76 citations
REDUCTION OF MORBIDITY AND CYTOKINE RELEASE IN ANTI-CD3 MoAb-TREATED MICE BY CORTICOSTEROIDS
1990 • 62 citations
Nosocomial Aseptic Meningitis Associated With Administration of OKT3
1988 • 62 citations
Genetic control of lipopolysaccharide induced generation of serum colony stimulating factor and proliferation of splenic granulocyte/macrophage precursor cells
1976 • 53 citations
Clinical development of Orthoclone OKT3.
1987 • 53 citations
ACTIVATION OF HUMAN T CELLS IN VIVO FOLLOWING TREATMENT OF TRANSPLANT RECIPIENTS WITH OKT3
1990 • 49 citations
Anti-TNF abrogates the cytokine-related anti-CD3 induced syndrome.
1991 • 26 citations
Clinical use of OKT3: The role of cytokine release and xenosensitization
1988 • 25 citations
OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
1986 • 13 citations